# FDA recall Z-0621-2021

> **Biomet, Inc.** · Class II · device recall initiated 2020-11-25.

## Product

Custom Cancellous Thread, Item numbers CP161941,   CP161943 - Product Usage:  1. Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis 3. Correction of functional deformity 4. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques. 5. Revision of previously failed total hip arthroplasty.

## Reason for recall

Specific lots of multiple sterile medical devices may have a breach in the sterile seal. A breach in the packaging seal could lead to loss of sterility of the device.

## Distribution

Worldwide distribution. US nationwide, ARGENTINA, AUSTRALIA, Brazil,  CANADA, CHILE, CHINA, COSTA RICA, EMEA, HONG KONG, INDIA, JAPAN, KOREA, MALAYSIA, NEW ZEALAND, SINGAPORE, and TAIWAN

## Key facts

- **Recall number:** Z-0621-2021
- **Recalling firm:** Biomet, Inc.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2020-11-25
- **Report date:** 2020-12-23
- **Termination date:** 2024-05-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Warsaw, IN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0621-2021

## Citation

> AI Analytics. FDA recall Z-0621-2021. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/Z-0621-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*